CL - Colgate-Palmolive Company
| Previous close | 65.47 |
| Open | 65.36 |
| Bid | 64.04 x 1400 |
| Ask | 68.47 x 1100 |
| Day's range | 64.88 - 65.65 |
| 52-week range | 57.41 - 77.91 |
| Volume | 4,975,960 |
| Avg. volume | 4,675,434 |
| Market cap | 56.523B |
| Beta (3Y monthly) | 0.68 |
| PE ratio (TTM) | 26.97 |
| EPS (TTM) | 2.42 |
| Earnings date | 25 Jan 2019 |
| Forward dividend & yield | 1.68 (2.57%) |
| Ex-dividend date | 2018-10-18 |
| 1y target est | 62.98 |
Market Realist•9 days agoRecovery in Colgate-Palmolive Stock Could Be Short-Lived
Colgate-Palmolive (CL) stock outperformed the broader markets in November and increased 6.7%. Colgate-Palmolive’s top line is projected to remain low during the fourth quarter, which reflects the negative impact from currency rates and challenging market conditions in China and Brazil. Analysts expect Colgate-Palmolive’s fourth-quarter EPS to decline on a year-over-year basis due to lower sales and weak margins.
Market Realist•9 days agoChurch & Dwight Stock Outperformed Its Peers
Church & Dwight (CHD) stock has risen 32.7% on a YTD basis due to the company’s strong financial performance in 2018. The company’s top and bottom line have grown at a phenomenal rate in 2018. Other major consumer packaged goods companies including Colgate-Palmolive (CL), Kimberly-Clark (KMB), and Procter & Gamble (PG) have struggled to lift their sales and EPS growth rate. Church & Dwight sustained the momentum during the third quarter, while the stock rose 11.55 in November.
Market Realist•9 days agoWhich CPG Stocks Outperformed the Markets in November?
Shares of major CPG (consumer packaged goods) manufacturers showed a healthy recovery in November and outperformed the benchmark index (SPX). Shares of Church & Dwight (CHD), Clorox (CLX), Kimberly-Clark (KMB), Procter & Gamble (PG), and Colgate-Palmolive (CL) increased 11.5%, 11.6%, 10.6%, 6.6%, and 6.7%, respectively, in November. In comparison, the S&P 500 Index increased 1.8% during the same period.
- Zacks•9 days ago
Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day
Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day
- Zacks•9 days ago
Colgate (CL) Stock Down 14.3% YTD: What You Should Know
Colgate's (CL) dismal performance can be attributed to uncertain global markets. Also, a dismal sales trend is worrisome. However, the company's savings programs appear impressive.
Market Realist•16 days agoWhy Wall Street Expects Downside in KMB Stock
Wall Street analysts maintain a target price of $105.65 per share on Kimberly-Clark (KMB) stock, which indicates a downside of 8.5%, based on its closing price of $115.45 on November 27. Analysts expect Kimberly-Clark’s soft sales and weak margins to hurt its stock in the near term. Kimberly-Clark’s top line is expected to decline in the next couple of quarters, reflecting adverse currency rates and challenging market conditions in China.
- Market Realist•16 days ago
Why KMB’s EPS Could Disappoint in the Near Term
Analysts expect Kimberly-Clark’s bottom line to take a hit from soft sales and cost headwinds in the near term. A higher tax rate is likely to affect the 2019 EPS growth rate. Analysts expect Kimberly-Clark to report adjusted earnings of $1.66 per share in the fourth quarter of 2018, which reflects year-over-year or YoY growth of 5.7%.
Market Realist•17 days agoWhy Kimberly-Clark’s Margins Are Expected to Decline
Kimberly-Clark’s (KMB) profit margins remained weak in the first nine months of 2018, and the trend is likely to continue as challenges persist, at least in the near term. Kimberly-Clark’s management expects inflation in commodities, including pulp and other raw materials, to continue to hurt its gross margins despite the benefits from a favorable mix, higher pricing, and cost savings. Weak gross margins are likely to hurt operating margins during the fourth quarter.
- Market Realist•17 days ago
Why KMB’s Sales Are Projected to Fall in the Near Term
Wall Street expects Kimberly-Clark’s sales (KMB) to remain weak in the near term, at least over the next couple of quarters. Analysts expect Kimberly-Clark’s net sales to decline 2.7% in the fourth quarter of 2018. Meanwhile, its top line is forecast to fall 4.1% in the first quarter of 2019.
Market Realist•17 days agoWill Sales and Cost Headwinds Stall the Recovery in KMB Stock?
Shares of Kimberly-Clark (KMB) have increased 8.5% since the company reported better-than-expected third-quarter results on October 22. Kimberly-Clark’s third-quarter top and bottom lines came in ahead of analysts’ estimates, thanks to higher pricing, a favorable mix, a lower effective tax rate, and share repurchases.
- Zacks•18 days ago
New Strong Sell Stocks for November 27th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
- Zacks•20 days ago
Why Is Colgate-Palmolive (CL) Down 3.2% Since Last Earnings Report?
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Market Realist•25 days agoHow CHD Has Outperformed Its Bigger Rivals This Year
Church & Dwight (CHD) stock has had a phenomenal run so far this year. Church & Dwight’s focus on innovation, incremental sales from recent acquisitions, investments in its international business, and a balanced portfolio of value and premium products drove its top line. Strong sales growth and tax reforms have driven Church & Dwight’s bottom line, which has grown at a double-digit rate in the past four quarters and has outperformed Wall Street’s expectations.
Market Realist•last monthWhat PG’s Target Price and Valuation Indicate
The majority of Wall Street analysts providing recommendations on Procter & Gamble (PG) stock maintain a neutral outlook. Wall Street expects near-term cost headwinds and unfavorable currency rates to hurt the company’s net sales and EPS growth rate. However, innovation-driven products, productivity savings, and a lower effective tax rate are projected to support the top and bottom lines.
Market Realist•last monthPG Continues to Beat EPS Estimates, but Growth Rate Slows
Procter & Gamble (PG) has impressed with its earnings despite facing strong sales and margin headwinds in the recent past. The company outperformed analysts’ estimates in the past 14 quarters with an average positive surprise of 4.3%, which is impressive. Focus on productivity and cost savings, a considerable decline in the effective tax rate, and share repurchases have helped the company to surpass analysts’ expectations.
- Market Realist•last month
Why PG’s Margins Could Continue to Fall in the Near Term
Procter & Gamble (PG) announced price increases across several product categories aimed at offsetting the adverse impact from the foreign exchange rate and continued inflation in commodities. However, we expect the company’s margins to remain weak and continue to slide, at least in the near term.
Market Realist•last monthWhy PG’s Top Line Could Remain Weak in the Near Term
PG Stock Is Up 15.2% since Q1 Results: Will Uptrend Continue? The company’s organic sales came in better than what analysts expected and rose 4% thanks to the improvement in volumes across all business segments and the favorable mix in the beauty segment. Despite strong organic sales growth, Procter & Gamble’s net sales growth remained low, reflecting the adverse impact from the foreign exchange rate.
Market Realist•last monthPG Stock Is Up 15.2% since Q1 Results: Will Uptrend Continue?
Procter & Gamble stock (PG) has seen a healthy recovery since the company reported stronger-than-expected first-quarter results on October 19. Procter & Gamble’s sales and earnings surpassed Wall Street’s expectations, and its 4% organic sales growth rate during the first quarter of fiscal 2019 impressed investors. Higher volumes across all business segments and its positive mix in the beauty segment supported the company’s organic sales growth.
Motley Fool•last monthWhy Colgate-Palmolive Stock Lost 11% in October
Investors weren't smiling after hearing that sales growth turned negative in the fiscal third quarter.
- GlobeNewswire•last month
Analysis: Positioning to Benefit within RE/MAX, New Residential Investment, General Motors, Summit Hotel Properties, CorEnergy Infrastructure Trust, and Colgate-Palmolive — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Nov. 06, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Market Realist•last monthDoes Wall Street Expect a Correction in Church & Dwight Stock?
Wall Street analysts have a consensus target price of $61.79 per share on Church & Dwight (CHD) stock, which implies a downside of 6.5% based on its closing price of $66.06 on November 2.
Market Realist•last monthWill Valuation Stall the Rally in Church & Dwight Stock?
Shares of Church & Dwight (CHD) have outperformed the benchmark index as well as its peers so far this year. Church & Dwight has managed to generate stellar sales and earnings growth at a time when most leading household and personal care product manufacturers in North America are struggling to defend their market shares. Church & Dwight’s strong portfolio of value and premium brands, its focus on innovation-led products, its export expansion, and the benefits it’s garnered from strategic acquisitions are driving its top line, which has risen at an average rate of 12.9% in the past four quarters.
Market Realist•last monthClorox Beats Its Q1 2019 Estimates, EPS Guidance Disappoints
Clorox (CLX) reported stronger-than-expected results for the first quarter of fiscal 2019—the period ending on September 30. The company’s top line beat analysts’ estimate and improved 4% on a YoY (year-over-year) basis due to the acquisition, higher pricing, and improved volumes. However, divestiture and negative currency rates remained a drag.
- Zacks•last month
New Strong Sell Stocks for October 31st
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
